AMGN Amgen
- 298.840
- -22.970-7.14%
- 308.470
- +9.630+3.22%
Amgen News
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Khosla Rachna
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Busch Matthew C.
Amgen | 4: Statement of changes in beneficial ownership of securities-Director ISHRAK OMAR
Amgen | 4: Statement of changes in beneficial ownership of securities-Director HOLLEY CHARLES M
Amgen | 4: Statement of changes in beneficial ownership of securities-Director Drake Michael V
Amgen | 10-Q: Q3 2024 Earnings Report
Amgen | 8-K: AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
Amgen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Amgen | 4: Statement of changes in beneficial ownership of securities-Director ISHRAK OMAR
Amgen | 4: Statement of changes in beneficial ownership of securities-Director HOLLEY CHARLES M
Amgen | 4: Statement of changes in beneficial ownership of securities-Director Drake Michael V
Amgen | 10-Q: Q2 2024 Earnings Report
Amgen | 8-K: AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Grygiel Nancy A.
Amgen | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Amgen | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Amgen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Amgen | 4: Statement of changes in beneficial ownership of securities-Director MILES AMY E
Amgen | 4: Statement of changes in beneficial ownership of securities-Director Kullman Ellen Jamison
Amgen | 4: Statement of changes in beneficial ownership of securities-Director Klotman Mary E.
Analysis
Price Target
No Data
No Data
